Project no.: 2023/380547

Program name: SMEs Growth Romania – Boost to Romanian Business sector: Business

Growth in Start-ups – 2nd call

Project name: Restricted call application − CorFlow API Exposure − AI-based Computer Aided Medical System Capabilities Exposure with API Service

Project Promoter: SC AUTOSYMED SRL

Autosymed is an AI precision imagistics company that enhances doctors’ abilities and skills to serve their patients better. CadFlow application uses advanced, custom-developed AI algorithms and tools to enable more precise and quicker diagnosis of Coronary Artery Disease (CAD).

Autosymed finalized a project sponsored by the Innovation Norway program to identify strategic aspects and define the roadmap for future growth. The CadFlow improved accuracy and precision, making the process four times faster and enhancing quality. The solution will be further optimized for regulations and local procedures to meet the new growth strategy. Autosymed realigned a growth strategy for expanding Romanian, Polish, German, and British markets. The company also applied for patent and trademark protection to continue its brand know-how security master plan.

The coronary artery segmentation module, a crucial component of the CadFlow system for AI-based cardiac diagnosis, has significantly improved its precision and accuracy. Professional cardiologists confirmed that the process is four times faster and with enhanced suggestions quality, impacting more precise diagnostics. The improvements are based on retraining the AI model on thousands of new cases.

Autosymed has developed an expansion plan for international markets. The newly developed marketing strategy is paving the way to become the first to automate the most commonly widespread disease diagnosis, coronary artery disease, which is severe in German, British, Polish, and Romanian societies.

Expanding to new markets depends on adapting to local markets, cultures, and legal requirements. The CadFlow product has been analyzed to create a deployment plan that includes adaptation to regulations and local procedures within target markets.

Innovative enterprises must protect their R&D value. Autosymed has already applied for patent and trademark protection and will continue its brand know-how security master plan. The company also took a strategic approach to securing IP and trademarks and defining a tailored go-to-market strategy. Both aspects were the subject of the 3rd Norway Fund, which they accessed and developed over the past months. Autosymed conducted extensive research on innovation and singularity and confirmed hard-to-copy features by competitors.

For more details, please check
 https://www.autosymed.com